English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 20, 2026

Kyverna prepares to submit first CAR T therapy for autoimmune disease to FDA
+ Pharmaceuticals
Patient Daily | Jul 20, 2026

FDA transparency policy for rejection letters faces legal and procedural challenges
+ Pharmaceuticals
Patient Daily | Jul 20, 2026

Semaglutide drives surge in GLP-1RA use as patient costs fall but total payments rise
+ Pharmaceuticals
Patient Daily | Jul 20, 2026

Study suggests thrombectomy may benefit stroke patients with pre-existing disabilities
+ Pharmaceuticals
Patient Daily | Jul 20, 2026

Researchers identify four specialized cell types driving intestinal lining renewal
+ Pharmaceuticals
Patient Daily | Jul 20, 2026

Type 1 diabetes pipeline advances toward insulin independence with new therapies and trials
+ Pharmaceuticals
Patient Daily | Jul 20, 2026

Analysts say Vertex’s IgA nephropathy drug benefits from recent FDA approvals
+ Pharmaceuticals
Patient Daily | Jul 20, 2026

AI-guided technique may improve targeted therapy for brain tumors

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation